Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $10,700 - $17,000
5,000 New
5,000 $10,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $8,350 - $14,700
5,000 New
5,000 $12,000
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $41,650 - $78,625
-42,500 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.76 - $6.38 $74,800 - $271,150
42,500 New
42,500 $75,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.09B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.